ArticlePharmaceuticals (Basel, Switzerland)2022

New IMB16-4 Nanoparticles Improved Oral Bioavailability and Enhanced Anti-Hepatic Fibrosis on Rats.

Xia Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.